Results 21 to 30 of about 5,317,572 (397)

Ovarian Cancer Immunotherapy and Personalized Medicine

open access: yesInternational Journal of Molecular Sciences, 2021
Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may improve the predictiveness of response to immunotherapy.
Susan Morand   +4 more
semanticscholar   +1 more source

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

open access: yesCommunications Biology, 2022
L1CAM is implicated as an important factor that enables early fallopian tube cancer precursors to seed the ovary by promoting cell survival through extracellular matrix signaling, thereby facilitating ovarian cancer growth.
Kai Doberstein   +13 more
doaj   +1 more source

Ovarian cancer screening [PDF]

open access: yesCancer, 1991
AbstractBackground. Despite advances in evaluation and treatment, ovarian cancer mortality has decreased minimally during the past two decades. Most patients have advanced‐stage disease at diagnosis, and the prognosis is poor. As a result, there has been increasing interest in the development of methods for the early detection of ovarian cancer.
Edward J. Pavlik   +3 more
openaire   +7 more sources

Inflammation and Ovarian Cancer [PDF]

open access: yesCytokine, 2012
Epithelial ovarian cancer (EOC) is a highly lethal gynecological cancer for which overall prognosis has remained poor over the past few decades. A number of theories have been postulated in an effort to explain the etiology of EOC. Noteworthy, these theories likely are not mutually exclusive, as they all converge more or less on the role of ...
Maccio' A, MADEDDU, CLELIA
openaire   +5 more sources

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

open access: yesBMC Cancer, 2017
Background Epithelial ovarian cancer exhibits extensive interpatient and intratumoral heterogeneity, which can hinder successful treatment strategies.
Jessica G. Tong   +7 more
doaj   +1 more source

Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems

open access: yesJournal of Ovarian Research, 2023
Epithelial ovarian cancer (EOC) research has become more complex as researchers try to fully understand the metastatic process. Especially as we delve into the concept of tumour dormancy, where cells transition between proliferative and dormant states to
Emily Tomas, Trevor G. Shepherd
doaj   +1 more source

Ovarian cancer statistics, 2018

open access: yesCa, 2018
In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and 14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society provides an overview of ovarian cancer occurrence based on incidence data from ...
Lindsey A. Torre   +8 more
semanticscholar   +1 more source

Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer. [PDF]

open access: yes, 2015
The objective of this study was to evaluate the correlation between 25-OH vitamin D and ovarian cancer as a diagnostic marker or recurrence disease marker.
Anastasi, Emanuela   +6 more
core   +1 more source

HE4 in the differential diagnosis of ovarian masses [PDF]

open access: yes, 2015
Ovarian masses, a common finding among pre- and post-menopausal women, can be benign or malignant. Ovarian cancer is the leading cause of death from gynecologic malignancy among women living in industrialized countries.
ANASTASI, Emanuela   +5 more
core   +1 more source

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

open access: yesNew England Journal of Medicine, 2018
BACKGROUND Most women with newly diagnosed advanced ovarian cancer have a relapse within 3 years after standard treatment with surgery and platinum‐based chemotherapy.
K. Moore   +20 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy